Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Alexandros L Liarakos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK. Hauptthemen laut MEDLINE: Renal Dialysis, Patient Reported Outcome Measures, Insulin, Diabetic Nephropathies. Die Arbeit nennt 38 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To assess key patient‐reported outcomes (PROs) in individuals with insulin‐treated diabetes receiving haemodialysis and examine associations between continuous glucose monitoring (CGM) metrics, HbA1c and PROs. Materials and Methods In this cross‐sectional study, adults with insulin‐treated diabetes receiving haemodialysis and using CGM were recruited. PROs included glucose monitoring satisfaction (GMSS), diabetes distress (DDS‐17, PAID), kidney failure–related symptom burden (IPOS‐Renal), thirst (Dialysis Thirst Inventory) and hypoglycaemia awareness (Gold score). CGM metrics were defined according to international consensus recommendations. Multivariable regression analyses examined associations between CGM metrics, HbA1c and PROs.
Results
Forty participants were included. CGM satisfaction was high (median GMSS 4.5 [IQR 3.9–4.7]) with low CGM use‐related burden. Overall diabetes distress was low (median DDS‐17 1.7 [1.3–2.2]), although emotional burden was frequently reported. Kidney failure–related symptom burden was high. Thirst was common, with 65% of participants reporting problematic thirst. CGM metrics were consistently associated with multiple PROs, whereas HbA1c showed fewer associations. Higher time in range (3.9–10.0 mmol/L) was associated with greater CGM satisfaction (total GMSS score; unstandardised coefficient [ B ] 0.009, p = 0.044), lower regimen‐related distress ( B − 0.012, p = 0.040) and lower odds of problematic thirst (OR 0.79 per 5% increase, p = 0.021) and intradialytic thirst (OR 0.77, p = 0.017). Higher HbA1c was associated with increased odds of problematic thirst (OR 2.30 per 11 mmol/mol increase, p = 0.014) and nocturnal thirst (OR 1.66, p = 0.040). Most had intact hypoglycaemia awareness (35/40, 87.5%).
Conclusion
In individuals with insulin‐treated diabetes receiving haemodialysis, CGM metrics were consistently associated with patient‐reported experience, particularly thirst, and may provide clinically relevant insights beyond HbA1c. Further studies should evaluate whether optimising glycaemic exposure translates into improved patient‐reported outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK.
- School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
- Department of Renal Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK.
- Centre for Kidney Research and Innovation, School of Medicine, University of Nottingham, Nottingham, UK.
- Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
- Department of Diabetes, Imperial College Healthcare NHS Trust, London, UK.
ORCID-Profile: Alexandros L Liarakos, Nicholas M Selby, Iskandar Idris
Zitieren
APA
Liarakos, A. L., Randhay, A., Leelarathna, L., Crabtree, T. S. J., Doleman, B., Eldehni, M. T., Selby, N. M., Taal, M. W., Idris, I., & Wilmot, E. G. (2026). Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70954
Vancouver
Liarakos AL, Randhay A, Leelarathna L, Crabtree TSJ, Doleman B, Eldehni MT, et al. Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70954
BibTeX
@article{Liarakos2026,
author = {Liarakos, Alexandros L and Randhay, Ashveer and Leelarathna, Lalantha and Crabtree, Thomas S J and Doleman, Brett and Eldehni, Mohamed Tarek and Selby, Nicholas M and Taal, Maarten W and Idris, Iskandar and Wilmot, Emma G},
title = {Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70954}
}
EUVIMED